TCT-13 Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Pieter C. Smits,Kaiyum Sheikjoesoef,Kees-Jan Royaards,Georgios Vlachojannis,Elvin Kedhi,Jochem Wassing,Eugene McFadden,Carlos Van Mieghem,Martin van der Ent

TCT-13 Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

2013

Pieter C. Smits
Kaiyum Sheikjoesoef
Kees-Jan Royaards
Georgios Vlachojannis
Elvin Kedhi
Jochem Wassing
Eugene McFadden
Carlos Van Mieghem
Martin van der Ent

Longterm results with drug eluting stents are important considering late differences in stent thrombosis, neo-athererosclerosis and catch-up phenomena that has been observed in several stent studies. Furthermore, little is known of longterm results with the everolimus-eluting stent, specifically in

Keywords:

Randomized controlled trial
Thrombosis
Paclitaxel
Stent
Internal medicine
Cardiology
Everolimus
Medicine
stent thrombosis
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations